This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $9.15 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Degenhardt, L. et al. Global burden of disease attributable to illicit drug use and dependence: findings from the global burden of disease study 2010. Lancet 382, 1564–1574 (2013).
Faherty, L. J., Matone, M., Passarella, M. & Lorch, S. Mental health of mothers of infants with neonatal abstinence syndrome and prenatal opioid exposure. Mat. Child Health J. 22, 841–848 (2018).
Benningfield, M. M. et al. Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women. Am. J. Addict. 19, 416–421 (2010).
Wachman, E. M. et al. The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome. J. Addict. Med. 5, 293–299 (2011).
Grigoriadis, S. et al. The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J. Clin. Psychiatry 74, e309–e320 (2013).
Huybrechts, K. F. et al. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: a cohort study. BMJ 358, J33266 (2017).
Bakhireva, L. N. et al. Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors. Pediatr Res. (2021). Epub ahead of print.
Salisbury, A. L. et al. The roles of maternal depression, serotonin reuptake inhibitor treatment, and concomitant benzodiazepine use on infant neurobehavioral functioning over the first postnatal month. Am. J. Psychiatry 173, 147–157 (2016).
Lester, B. M. & Tronick, E. Z. History and description of the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics 113, 634–640 (2004).
Flannery, T. et al. Neonatal Abstinence Syndrome Severity Index predicts 18-month neurodevelopmental outcome in neonates randomized to morphine or methadone. J. Pediatr. 227, 101–107 (2020).
Liu, J. et al. Neonatal neurobehavior predicts medical and behavioral outcome. Pediatrics 125, e90–e98 (2010).
Haapakoski, R., Mathieu, J., Ebmeier, K. P., Alenius, H. & Kivimaki, M. Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain Behav. Immun. 49, 206–215 (2015).
Leff-Gelman, P. et al. The immune system and the role of inflammation in perinatal depression. Neurosci. Bull. 32, 398–420 (2016).
Seth, S., Lewis, A. J. & Galbally, M. Perinatal maternal depression and cortisol function in pregnancy and the postpartum period: a systematic literature review. BMC Pregnancy Childbirth 16, 124 (2016).
Rodriguez, N., Vining, M. & Bloch-Salisbury, E. Salivary cortisol levels as a biomarker for severity of withdrawal in opioid-exposed newborns. Pediatr. Res. 87, 1033–1038 (2020).
Conradt, E., Lester, B. M., Appleton, A. A., Armstrong, D. A. & Marsit, C. J. The roles of DNA methylation of NR3C1 and 11b-HSD2 and exposure to maternal mood disorder in utero on newborn neurobehavior. Epigenetics 8, 1321–1329 (2013).
Gluckman, P. D., Hanson, M. A., Cooper, C. & Thornburg, K. L. Effect of in utero and early-life conditions on adult health and disease. N. Engl. J. Med. 359, 61–73 (2008).
Ostlund, B. D. et al. Maternal mindfulness during pregnancy predicts newborn neurobehavior. Dev. Psychobiol. 63, e22131 (2021).
Chin Foo, C. A., Dansereau, L. M., Hawes, K., Oliveira, E. L. & Lester, B. M. Improving the assessment of neonatal abstinence syndrome. Children 8, 685 (2021).
Patrick, S. W., Kaplan, H. C., Passarella, M., Davis, M. M. & Lorch, S. A. Variation in treatment of neonatal abstinence syndrome in US Children’s Hospitals, 2004-2011. J. Perinatol. 34, 867–872 (2014).
Young, W. et al. Site-level variation in the characteristics and care of infants with neonatal opioid withdrawal. Pediatrics 147, e2020008839 (2021).
Jansson, L. M. & Velez, M. L. Optimal care for NAS: Are we moving in the wrong direction? Hosp. Pediatr. 9, 655–658 (2019).
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Lester, B.M., Davis, J.M. Disarray in the perinatal management of neonatal abstinence syndrome. Pediatr Res (2021). https://doi.org/10.1038/s41390-021-01848-1